Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 17,301–17,325 of 27,380 studies, newest first · page 693 of 1096.

January 2015 25

  1. 2015-01-14

    A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

    ✓ Peer-reviewed Biomarkers Journal of neurology, neurosurgery, and psychiatry

    Key finding: A panel of nine CSF biomarkers was able to differentiate APS from patients with PD and dementia. +1 more finding

  2. 2015-01-14

    RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration

    ✓ Peer-reviewed Disease mechanisms Nature

    Key finding: RBM3 overexpression, achieved either by boosting endogenous levels through hypothermia before the loss of the RBM3 response or by lentiviral delivery, resulted in sustained synaptic protection in 5XFAD mice and throughout the course of prion disease, preventing behavioural deficits and neuronal loss and significantly prolonging survival.

  3. 2015-01-13

    Obstructive sleep apnea in young infants with Down Syndrome evaluated in a Down Syndrome specialty clinic

    ✓ Peer-reviewed Risk factors American Journal of Medical Genetics Part A

    Key finding: The minimum overall prevalence of OSA among the larger group of infants was 31% (56/177). +3 more findings

  4. 2015-01-13

    ApoE Type 4 Allele Affects Cognitive Function of Aged Population in Tianjin City, China

    ✓ Peer-reviewed Genetics American Journal of Alzheimer's Disease & Other Dementias®

    Key finding: The results indicate that ApoE∊4 has significant negative effect on the cognitive function of the elderly people who are 60 years and older.

  5. 2015-01-13

    Neuropsychiatric symptoms in Parkinson's disease dementia are associated with increased caregiver burden

    ✓ Peer-reviewed Caregiving Journal of movement disorders

    Key finding: All but one patient showed one or more neuropsychiatric symptoms. +4 more findings

  6. 2015-01-13

    Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study

    ✓ Peer-reviewed Clinical safety The American journal of psychiatry

    Key finding: Specific neuropsychiatric symptoms are associated with shorter survival time from mild Alzheimer's dementia to severe dementia and/or death. +4 more findings

  7. 2015-01-13

    Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications

    ✓ Peer-reviewed Drug development Cardiovascular diabetology

    Key finding: Indeed, accumulating evidence has suggested the active involvement of accumulation of AGEs in diabetes-associated disorders such as diabetic microangiopathy, atherosclerotic cardiovascular diseases, Alzheimer's disease and osteoporosis. +4 more findings

  8. 2015-01-13

    A major role for cardiovascular burden in age-related cognitive decline

    ✓ Peer-reviewed Caregiving Nature reviews. Cardiology

    Key finding: Mixed dementia, resulting from both cerebrovascular lesions and neurodegeneration, accounts for the majority of dementia cases among very old individuals (≥75 years). +4 more findings

  9. 2015-01-13

    Plasma levels of apolipoprotein E and risk of dementia in the general population

    ✓ Peer-reviewed Genetics Annals of neurology

    Key finding: Low plasma levels of apoE are associated with increased risk of future Alzheimer disease and all dementia in the general population, independent of ε2/ε3/ε4 APOE genotype. +2 more findings

  10. 2015-01-12

    Regulator of G‐protein signalling 5 protects against atherosclerosis in apolipoprotein E‐deficient mice

    ✓ Peer-reviewed Genetics British Journal of Pharmacology

    Key finding: Atherosclerotic phenotypes were significantly accelerated in RGS 5 −/− ApoE −/− mice, as indicated by increased inflammatory mediator expression and apoptosis of endothelial cells and macrophages. +4 more findings

  11. 2015-01-12

    Geographical Variation in Dementia

    ✓ Peer-reviewed Risk factors Epidemiology

    Key finding: We found a 2- to 3-fold geographical variation in dementia odds in Sweden, after twin random effects-likely to capture genetic and shared environmental variance-were removed. +4 more findings

  12. 2015-01-12

    Personality and Cognitive Decline in Older Adults: Data From a Longitudinal Sample and Meta-Analysis

    ✓ Peer-reviewed Prevention and risk The journals of gerontology. Series B, Psychological sciences and social sciences

    Key finding: Personality is associated with cognitive decline in older adults, with effects comparable to established clinical and lifestyle risk factors. +4 more findings

  13. 2015-01-10

    Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials

    ✓ Peer-reviewed Drug development Journal of general internal medicine

    Key finding: Statin therapy was not associated with cognitive impairment in RCTs. +4 more findings

  14. 2015-01-09

    Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies

    ✓ Peer-reviewed Drug development Biological psychiatry

    Key finding: In addition to the deposition of tau oligomers, our results also provide compelling evidence of co-occurrence of α-synuclein and tau into their most toxic forms, i.e., oligomers suggesting that these species interact and influence each other's aggregation via an interface in synucleinopathies. +3 more findings

  15. 2015-01-09

    Palliative care and quality of life for people with dementia: medical and psychosocial interventions

    ✓ Peer-reviewed End-of-life care International psychogeriatrics

    Key finding: Educating families and professionals about palliative care is important as many professionals and non-professionals believe that this approach intends to hasten death, instead of affirming life and regarding dying as a normal process. +1 more finding

  16. 2015-01-09

    Autonomous unobtrusive detection of mild cognitive impairment in older adults

    ✓ Peer-reviewed Digital health tools IEEE transactions on bio-medical engineering

    Key finding: Using the sensor and clinical data pertaining to 97 subjects, acquired over an average period of three years, a number of measures associated with the subjects' walking speed and general activity in the home were calculated.

  17. 2015-01-08

    Relationship between white matter hyperintensities, cortical thickness, and cognition

    ✓ Peer-reviewed Vascular contributions Stroke

    Key finding: These cross-sectional results suggest that cortical changes (regional-specific damage and network breakdown), mediated (in)directly by WMH (tract-specific damage) and other factors (eg, vascular risk factors), might lead to cognitive decline. +4 more findings

  18. 2015-01-08

    The Link Between Physical Activity and Cognitive Dysfunction in Alzheimer Disease

    ✓ Peer-reviewed Prevention trials Physical therapy

    Key finding: Most of the studies suggested that PA attenuates neuropathology and positively affects cognitive function in AD. +1 more finding

  19. 2015-01-07

    The Association Between Serum ApoE Genetic Polymorphism and Serum Lipid Level in Hemodialysis Patients

    ✓ Peer-reviewed Genetics Genetic Testing and Molecular Biomarkers

    Key finding: Growing evidence indicates that apolipoprotein E (ApoE) is one of the most important candidate genes for influencing the development of hemodialysis (HD). +2 more findings

  20. 2015-01-07

    The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease

    ✓ Peer-reviewed Disease mechanisms Molecular neurobiology

    Key finding: An impaired ubiquitin-proteasome system (UPS) could lead to negative consequences for protein regulation, including loss of function. +4 more findings

  21. 2015-01-07

    Dementia praecox redux: a systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia

    ✓ Peer-reviewed Prevention trials Journal of psychopharmacology (Oxford, England)

    Key finding: Overall data are underwhelming: some studies showed significant improvements in cognition but as many studies had negative findings.

  22. 2015-01-07

    Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression

    ✓ Peer-reviewed Genetics Neurology

    Key finding: The proportion of progressors was 11% (8/41), 34% (14/41), 56% (19/34), and 71% (60/85) in A-N-, A+N-, SNAP, and A+N+, respectively; the proportion of APOE ε4 carriers was 29%, 70%, 31%, and 71%, respectively, with the SNAP group featuring a significantly different proportion than both A+N- and A+N+ groups (p ≤ 0.005). +1 more finding

  23. 2015-01-06

    Targeting Hsp90/Hsp70-Based Protein Quality Control for Treatment of Adult Onset Neurodegenerative Diseases

    ✓ Peer-reviewed Disease mechanisms Annual Review of Pharmacology and Toxicology

    Key finding: Currently available therapies for adult onset neurodegenerative diseases provide symptomatic relief but do not modify disease progression. +4 more findings

  24. 2015-01-06

    Association of Alzheimer's disease GWAS loci with MRI markers of brain aging

    ✓ Peer-reviewed Genetics Neurobiology of aging

    Key finding: In single-SNP based tests, AD risk allele of APOE (rs2075650) was associated with smaller HV (p = 0.0054) and CD33 (rs3865444) with smaller intracranial volume (p = 0.0058). +3 more findings

  25. 2015-01-05

    An acetylation switch controls TDP-43 function and aggregation propensity

    ✓ Peer-reviewed Lewy body dementia Nature communications

    Key finding: Here, we identify lysine acetylation as a novel post-translational modification controlling TDP-43 function and aggregation. +4 more findings

Browse the library by subject, with the full score breakdown →